Update: Temple Health and Keystone First Family Health Plans have reached a new contract agreement. 

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

view all Clinical Trials

Overview

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to standard of care therapy on preventing or slowing the rate of lung function decline in adult patients with uncontrolled moderate to severe asthma.

Clinical Trial Information

Protocol

29276

Phase

4

Condition(s)

Asthma

Investigator

Kartik Shenoy, MD

Coordinator

Arwa Mukhtar, Dave Miller, Sheril George

Visit clinicaltrials.gov for full description.

Contact

This trial is not currently open for enrollment, but it is expected to re-open at a later date. For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma